On October 7, with comprehensive support from CIRS Group, Inner Mongolia Kingdomway Pharmaceutical Limited (hereinafter referred to as “Kingdomway”) officially received a “FDA Has No Questions Letter” from the U.S. Food and Drug Administration (FDA) for its fermentation-derived brazzein (GRAS Notice No. 001305). This milestone marks the successful completion of the FDA’s review of the company’s GRAS notice for the product.

China NHC issued notifications regarding the acceptance of “three new foods”. The applications for 3 new food materials (ingredients) and 4 new food additives have been received.

On September 20, 2026, the State Administration for Market Regulation (SAMR) released the FAQs on Labeling Requirements for Infant and Young Children Formula Foods (the “FAQs”), providing further clarification on labeling requirements for infant and young children formula milk powder and liquid formula. The FAQs address several key labeling issues, including the indication of production dates and shelf-life expiration dates, allergen statements, milk-source and organic certification claims, label changes and filing requirements, production by other companies within the same corporate group, and the transition between old and new labels.

The EFSA Panel concluded that rebaudioside M produced via a new enzymatic process using genetically modified E. coli enzymes raises no safety concerns. Because no viable cells, DNA, or significant enzyme residues remain, and its physicochemical profile matches approved Reb M, previous toxicological safety data applies, supporting a distinct new food additive entry.

The EFSA Panel concluded that chemically synthesized cannabidiol (≥98% purity) in MCT oil is safe as a novel food supplement for adults over 25—excluding pregnant, breastfeeding, or medicated individuals—at a safe maximum intake of 2 mg per day.

Recently, China's National Health Commission (NHC) issued notifications regarding the approval and review of “Three new foods” (new food raw materials, new food additives, and new food-related products). The notifications included 10 notifications of extension notice and 6 notifications of review opinions

China NHC issued notifications regarding the acceptance of “three new foods”. The applications for 2 new food materials and 7 new food additives have been received.

This successful FDA evaluation marks a major breakthrough in the product’s international compliance capabilities, providing a solid foundation for the company’s overseas business expansion and the implementation of its global strategy.

Driven by a global wave of food innovation, regulatory compliance and market access for novel food ingredients and additives have become critical hurdles for companies expanding internationally. Under these circumstances, CIRS Group has prepared the White Paper Series on Global Novel Food and Feed Ingredient Submissions, with the aim of helping businesses navigate the evolving global regulations and accelerate global expansion.

To help industry players navigate these compliance hurdles, CIRS Group has compiled the Guide to U.S. Animal Food Ingredient Regulatory Submissions: Animal Food GRAS Notices, Food Additive Petitions, FDA Animal Food Ingredient Consultation (AFIC), and AAFCO Scientific Review of Ingredient Submissions (SRIS).